The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 353:842-844 August 25, 2005 Number 8
NextNext

Cystatin C and the Risk of Death

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Shlipak, M. G.
-PubMed Citation
To the Editor: Shlipak et al. (May 19 issue)1 report on cystatin C and the risk of death and cardiovascular events among elderly persons. However, we have a comment on cystatin C as a measure of kidney function. In patients with hypothyroidism, levels of creatinine tend to be elevated, and in patients with hyperthyroidism, creatinine is lowered.2 In contrast, levels of cystatin C are low in cases of hypothyroidism and elevated in hyperthyroidism.3 However, the authors state in the Discussion section that "cystatin C levels appear to be elevated in patients with hypothyroidism and depressed in those with hyperthyroidism," citing . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.